Information displayed in this report may not trend or trigger automated decision support.â€¢ CANCERNEXT EXPANDED + RNAINSIGHTComponent3 wk agoGenetic Analysis OverallPOSITIVE: Pathogenic MutationsInterpretationOrder: 1111986315Resulting AgencyAMBRY GENETICSCORPORATIONDetected !INTERPRETATION REPORTSee Notes!AMBRY GENETICS LABComment: This individual is homozygous for the c.1293delA (p.K431Nfs*54) pathogenic mutation in the MBD4 gene.This result is consistent with a diagnosis of MBD4-associated neoplasia syndrome (MANS) .Risk estimate: increased risk for acute myelogenous leukemia and colorectal cancer.The expression and severity of disease for this individual cannot be predicted.Genetic testing for pathogenic mutations in family members can be helpful in identifying at-risk individuals.Genetic counseling is a recommended option for all individuals undergoing genetic testing.This individual is also heterozygous for the p.S755P (c.2263T>C) variant of unknown significance in the PDGERA gene, which may or may not contribute to this individual's clinical history. Refer to the supplementary pages for additional information on this variant. No additional pathogenic mutations, variants of unknown significance, or gross deletions or duplications were detected. Genes Analyzed (77 total): AIP, ALK, APC, ATM, BAP1, BARD1, BMPRIA, BRCA1, BRCA2, BRIP1, CDC73, CDH1, CDK4, CDKNIB, CDNA, CEBPA, CHEK2, DICER1,ETV6, FH, FLCN, GATA2, LZTRI, MAX, MENI, MET, MLH1, MSH2, MSH6, MUTYH, NE1,NE2, NTHL1, PALB2, PHOX2B, PMS2, POT1, PRKARIA, PTCH1, PTEN, RAD51C, RADSID,RB1, RET, RPS20, RUNXI, SDHA, SDHAF2, SDHB, SDHC, SDHD, SMAD4, SMARCA4,SMARCB1, SMARCE1, STK11, SUF, TMEM127, TP53, ISC1, TSC2, VHL and WT1sequencing anddeletion/duplication); AXIN2, CTNNA1, DDX41, EGER, HOXB13,KIT, MBD4,MITE, MSH3, PDGERA, POLD1 and POLE (sequencing only) ; EPCAM andall LEVEL OF SERVICE$ PRINT